
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a veterinarian's order for one animal patient. Not FDA-approved.
Fluoxetine is an FDA-approved animal drug. Animal Drugs@FDA lists one product, RECONCILE chewable tablets (NADA 141-272), labeled for the treatment of canine separation anxiety in conjunction with a behavior modification plan, for dogs 6 months of age or older. FDA notes that fluoxetine products approved for people can also be used extralabel when a veterinarian considers it appropriate. The Merck Veterinary Manual says SSRIs, including fluoxetine, have been used for conditions such as psychogenic alopecia, allergy-related itch, fearful and obsessive-compulsive behaviors and urine marking. These other uses are not FDA-approved. Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The RECONCILE label says not to use it in dogs with epilepsy or a history of seizures, with drugs that lower the seizure threshold such as acepromazine, or with an MAO inhibitor such as selegiline or amitraz. It says the most serious side effect is seizures, which in rare and severe cases can result in death, and that seizures may occur even in dogs without a seizure history. Other side effects include calmness or lethargy, decreased appetite, vomiting, shaking, diarrhea, restlessness, whining, aggression and weight loss. It is not recommended for aggression, and it has not been studied in breeding, pregnant or nursing dogs. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
Compounding from an approved fluoxetine product is extralabel use permitted under 21 CFR 530.13(b) only when no approved animal or human drug, used as labeled or in conformity with the extralabel criteria of part 530, will, in the available dosage form and concentration, appropriately treat the condition diagnosed; 530.13(a) excludes compounding from bulk. FDA reviewed fluoxetine for the GFI #256 office stock list for dogs, cats and horses and did not list it (12/21/2022). Because fluoxetine and norfluoxetine have long half-lives, the label calls for a 6-week washout after stopping RECONCILE before giving any drug that may interact adversely with them, and notes interactions with tricyclics have not been studied.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)